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To date there is compelling in vitro and in vivo evidence
for epidermal H2O2 accumulation in vitiligo. This paper
reviews the literature and presents new data on oxidative
stress in the epidermal compartment of this disorder.
Elevated H2O2 levels can be demonstrated in vivo in
patients compared with healthy controls by utilizing
Fourier-Transform Raman spectroscopy. H2O2 accumu-
lation is associated with low epidermal catalase levels. So
far, four potential sources for epidermal H2O2 generation
in vitiligo have been identified: (i) perturbed (6R)-L-
erythro 5,6,7,8 tetrahydrobiopterin (6BH4) de novo syn-
thesis/recycling/regulation; (ii) impaired catecholamine
synthesis with increased monoamine oxidase A activities;
(iii) low glutathione peroxidase activities; and (iv)
‘‘oxygen burst’’ via NADPH oxidase from a cellular
infiltrate. H2O2 overproduction can cause inactivation of
catalase as well as vacuolation in epidermal melanocytes
and keratinocytes. Vacuolation was also observed in vitro
Vitiligo is an acquired depigmentation disorder affecting0.5%–4% of the world population (Ortonne and Bose,1993). Despite its recognition several thousand yearsago, the etiology is still unclear. There are severalhypotheses proposed for the development of vitiligo but
none of them can satisfy the entire spectrum of this cosmetically
disfiguring disorder (LePoole et al, 1993a; Ortonne and Bose, 1993).
The clinical hallmark is the loss of constitutive pigment. Almost all
publications describe decreased numbers of functioning melanocytes
or complete absence of these cells in lesional skin (LePoole et al,
1993b; Ortonne and Bose, 1993). In addition, altered functionality of
keratinocytes and Langerhans cells has been documented (Schallreuter
and Pittelkow, 1988; Nordlund and Ortonne, 1992). Numerous
studies have been undertaken to identify melanocyte specific cytotoxic
antibodies to imply immunologic mechanisms in this disorder (Norris
et al, 1988a; Bystryn, 1989; Harning et al, 1991). An impaired growth
of melanocytes derived from ‘‘normal’’ epidermis of patients with
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in melanocytes established from lesional and nonlesional
epidermis of patients (n J 10) but was reversible upon
addition of catalase. H2O2 can directly oxidize 6BH4 to
6-biopterin, which is cytotoxic to melanocytes in vitro.
Therefore, we substituted the impaired catalase with a
‘‘pseudocatalase’’. Pseudocatalase is a bis-manganese III-
EDTA-(HCO3–)2 complex activated by UVB or natural
sun. This complex has been used in a pilot study on 33
patients, showing remarkable repigmentation even in
long lasting disease. Currently this approach is under
worldwide clinical investigation in an open trial. In
conclusion, there are several lines of evidence that the
entire epidermis of patients with vitiligo is involved in
the disease process and that correction of the epidermal
redox status is mandatory for repigmentation. Key words:
oxidative stress/tetrahydrobiopterin/repigmentation. Journal of
Investigative Dermatology Symposium Proceedings 4:91–96,
1999
vitiligo was previously observed under in vitro conditions showing
marked improvement after the addition of exogenous catalase (Medrano
and Nordlund, 1990; Boissy et al, 1991). Nowadays, there is accumulat-
ing evidence for increased oxidative stress of the entire epidermal
compartment in this disease (Moellmann et al, 1982; Bhawan and
Bhutani, 1983; Boissy et al, 1991; Schallreuter et al, 1991; Maresca
et al, 1997). This review includes the current evidence to support the
concept of oxidative stress in vitiligo.
LOW EPIDERMAL CATALASE LEVELS IN VITILIGO
The discovery of low epidermal catalase (EC 1.11.1.6) levels in both
lesional and nonlesional epidermis of patients with vitiligo suggested
for the first time that the entire epidermis may be involved in this
disorder (Schallreuter et al, 1991). Two possible conclusions stemmed
from this observation: (i) the heme active site of this enzyme could be
irreversibly inactivated by its own substrate, H2O2 (Aronoff, 1965),
and (ii) decreased expression of catalase mRNA could lead to lower
enzyme levels. Reverse transcriptase–polymerase chain reaction analysis
of catalase mRNA extracted from melanocytes and keratinocytes
established from healthy controls and patients did not show any
differences in expression (Fig 1). These earlier data were recently
supported by Maresca et al, who demonstrated decreased catalase
activities in melanocytes established from patients with vitiligo (Maresca
et al, 1997). In this context, it is interesting that melanocytes from
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Figure 1. Catalase mRNA expression in melanocytes. Unremarkable
mRNA expression of catalase in cell extracts from melanocytes established from
patients with vitiligo (n 5 5) compared with a healthy control using reverse
transcriptase–polymerase chain reaction analysis (55°C, 35 cycles) (from left to
right: negative control, 1, 2, 3 (lesional epidermis), 4, 5 (nonlesional epidermis),
6 (healthy control).
normal healthy individuals are more sensitive to H2O2 than keratino-
cytes, which could be due to their decreased catalase and glutathione
peroxidase activities (Norris et al, 1988b; Yohn et al, 1991). The
cardinal question arises, however, of where the H2O2 in vitiligo
originates from. To date there are at least four potential sources of
epidermal H2O2 generation identified in this disorder, in addition to
low epidermal catalase levels in lesional and nonlesional skin of
these patients.
Defective de novo synthesis/recycling/regulation of the cofactor (6R)-L-erythro
5,6,7,8 tetrahydrobiopterin (6BH4) in vitiligo In vitiligo, a defective
de novo synthesis/recycling/regulation of the essential cofactor 6BH4,
with concomitant micromolar accumulation of the isomer (7R)-L-
erythro 5,6,7,8 tetrahydrobiopterin (7BH4), has been shown in cell
extracts from epidermal suction blister tissue, and from melanocyte
and keratinocyte cell cultures established from the same material of
these patients (Schallreuter et al, 1994a, b). This impaired 6BH4 de novo
synthesis/recycling/regulation heralds several potential pitfalls for the
healthy survival of the epidermal unit.
1 The micromolar accumulation of the 7-isomer is sufficient to inhibit
phenylalanine hydroxylase (PAH; EC 1.14.16.1), and therefore high
epidermal levels of 7BH4 in vitiligo are in agreement with low enzyme
activities as observed in this patient group (Davis et al, 1992; Schallreuter
et al, 1994a, b). One consequence of inhibited PAH is the accumulation
of L-phenylalanine. Recently Fourier-Transform Raman spectroscopy
has been utilized in vivo to identify this accumulation of epidermal
L-phenylalanine, which further supports the inhibition of PAH in
vitiligo (Schallreuter et al, 1998a).
2 The inhibited enzyme together with the decreased 4a-hydroxy
tetrahydrobiopterin dehydratase (EC 3.4.5.10) in the recycling process
leads to a nonenzymic over-production of 7BH4 with a concomitant
accumulation of H2O2 due to an enhanced short circuit to quininoid
dihydropterin (Davis et al, 1992; Schallreuter et al, 1994b). Figure 2
summarizes our current understanding of the pathologic events in
vitiligo with regard to de novo synthesis/recycling/regulation of 6BH4
in association with accumulation of the 7-isomer.
Increased epidermal monoamine oxidase A (MAO-A) activities in vitiligo The
increased production of 6BH4 in epidermal keratinocytes established
from patients with vitiligo coincides with an enhanced norepinephrine
biosynthesis in these cells (Schallreuter et al, 1994b). These findings
were associated with increased MAO-A (EC 1.4.3.4) activities in the
entire epidermis, unveiling additional H2O2 stress as this metabolite is
a product of the catecholamine degrading enzymic reaction (Schallreuter
et al, 1996). Furthermore, it has been shown that norepinephrine
plasma levels as well as urinary levels of catecholamine metabolites are
Figure 2. De novo synthesis/recycling/regulation of 6BH4 in melanocytes
and keratinocytes. 6BH4 is synthesized de novo from GTP by the rate-limiting
enzyme GTP-cyclohydrolase I (GTP-CH-I) followed by two further enzymatic
steps [6-pyruvoyl tetrahydropterin synthase (PTPS), sepiapterin reductase (SR)].
The essential cofactor 6BH4 serves for the conversion of L-phenylalanine to
L-tyrosine by phenylalanine hydroxylase (PAH), leading to the formation of
4a-OH-carbinolamine (4a-OH-BH4) and the nonenzymatic production of
7BH4. 4a-OH-BH4 continues through the recycling program to quinonoid
dihydropterin via 4a-OH-BH4 dehydratase (4a-OH-BH4-DH), and is then
fully reduced to 6BH4 by an NADPH dependent reductase. The de novo
synthesis/recycling of 6BH4 is tightly controlled by the GTP-cyclohydrolase I
feedback regulatory protein (GFRP), where the binding of L-phenylalanine to
GFRP upregulates GTP-CH-I and 6BH4 binding to the protein downregulates
the de novo production of 6BH4 (Harada et al, 1993; Milstien et al, 1996). In
vitiligo 6BH4 is overproduced in association with increased GTP-CH-I and
extremely low DH activities. PAH activities are low as a consequence of 7BH4
inhibition concomitant with increased epidermal L-phenylalanine levels. This
scenario suggests that the feedback mechanism via GFRP must be impaired
because the downregulation of GTP-CH-I via GFRP/6BH4 does not function
in vitiligo. At the present time it remains unclear what the primary event is in
the perturbed 6BH4 homeostasis in this disorder.
significantly increased in these patients, particularly in active vitiligo
(Morrone et al, 1992; Schallreuter et al, 1994b). A perturbed catechol-
amine degradation in this disorder is also supported by increased
catecholamine-O-methyl transferase (COMT; EC 2.1.1.6) activities
(LePoole et al, 1994).
Age-dependent reduced glutathione peroxidase activities in vitiligo Determin-
ation of glutathione peroxidase (EC 1.11.1.9) activities in total blood
samples demonstrated significantly lower values in patients (n 5 36)
compared with controls (n 5 14) (Beazley et al, 1999). In this context,
it has also been demonstrated that no patients (n 5 61) revealed
selenium deficiency when compared with normal controls (n 5 5932,
normal range 0.80–1.20 µmol per liter); however, 56% of the group
had higher levels (range 1.20–2.00 µmol per liter). Because glutathione
peroxidase can provide a back-up system for catalase (Stryer, 1988),
these new findings suggest that the selenium-dependent enzyme is very
likely not compensated for by the selenium-independent glutathione
peroxidase. Hence, this important H2O2 degrading system also appears
to be impaired in vitiligo. Our results contradict earlier reports from
De Luca et al who found no significant difference in enzyme activities
between patients and controls (De Luca et al, 1997). Based on our
results, we conclude that oral supplementation with selenium in vitiligo
is unwarranted, as recommended by others.1
Possible production of H2O2 via the cellular infiltrate in active vitiligo Several
investigators have shown the presence of a cellular infiltrate in the
peri-lesional skin of patients with vitiligo (Ortonne and Bose, 1993).
Due to this infiltrate the biologic oxygen burst of these cells via
1Picardo M, Camera E, Maresca V, Pittarello A, Leonetti F, Passi S:
Antioxidant treatment in vitiligo. Pigment Cell Res 10:360, 1997 (abstr.)
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Figure 3. Identification of H2O2 using Fourier-Transform Raman
spectroscopy. The H2O2 peak (8.8 M) could be assigned in vitro to 875 cm
–1
based on the O–O stretch.
Figure 4. In vivo epidermal H2O2 generation using Fourier-Transform
Raman spectroscopy. In vivo H2O2 production by UVB (311 nm) is dose
dependent (0.15–0.9 J per cm2). Each measurement was taken directly after
UV exposure in healthy skin of photo skin type V [each data point presents
the mean of three measurements 6 SEM].
NADPH oxidase activities must also be taken into consideration for
additional H2O2 generation (Marks et al, 1996).
In vivo detection of H2O2 in the skin using Fourier-Transform
Raman spectroscopy Fourier-Transform Raman spectra were pro-
duced with a BRUKER RFS 100/S spectrometer equipped with a
liquid nitrogen cooled germanium detector. Sample excitation was
accomplished using a Nd31:YAG laser operating at 1064 nm with a
laser power of 400 mW. Each spectrum was accumulated over 5 min
with 300 scans and a resolution of 4 cm–1. Total H2O2 was assigned
as a well-defined peak at 875 cm–1 based on the O–O stretch (8.8 M)
(Fig 3). Using this method it is possible to identify in vivo directly
Figure 5. Sequential oxidation of 6BH4 to 6-biopterin. 6BH4 (0.2 3
10–6 M) was oxidized by H2O2 (0.6 3 10
–6 M) directly to 6-biopterin over
20 min. The spectra were scanned every 2 min, showing a shift of the peak
from 6BH4 to 6-biopterin. The isosbestic points prove the full direct 4-electron
oxidation to 6-biopterin.
dose-dependent H2O2 generation in normal healthy skin following
UVB exposure using TL01 bulbs with a narrow band output (maximum
at 311 nm, range 310–315) (Fig 4). Furthermore, we were able to
confirm in vivo increased epidermal H2O2 production in vitiligo using
this noninvasive method in 10 patients with active disease compared
with healthy controls. There were no significant H2O2 levels detectable
in normal healthy skin with different photo skin types (Fitzpatrick
classification) under the same experimental conditions.
CONSEQUENCES OF EPIDERMAL H2O2 ACCUMULATION
IN VITILIGO
The importance of the epidermal 6BH4/6-biopterin redox
status One consequence of 6BH4 and 7BH4 overproduction in
vitiligo in association with H2O2 accumulation is the full oxidation of
these reduced pterins to 6- and 7-biopterin, respectively. Figure 5
presents the kinetics for the sequential H2O2 oxidation of 6BH4 by
scanning every 2 min over a period of 20 min. It is noteworthy,
however, that 6BH4 can also be partially photo-oxidized specifically by
low-dose UVB exposure yielding 7,8-dihydroxanthopterin (Armarego
et al, 1983; Armarego, 1984; Schallreuter et al, 1998b). Moreover, it
is interesting that UVA cannot promote this reaction at any wavelength
under the same experimental conditions (Schallreuter et al, 1998b).
Furthermore, under in vitro conditions 6-biopterin is cytotoxic to
normal healthy melanocytes in the 10–7 M range, meanwhile 7-
biopterin has no effect under the same conditions (Schallreuter et al,
1994c). At present the physiologic role of the nonenzymatically
produced 7BH4 remains obscure. The micromolar production of 7BH4
in vitiligo has significant consequences leading to inhibition of PAH
activities in close association with the H2O2-producing short circuit
in the recycling process of 6BH4 (Davis et al, 1992; Schallreuter et al,
1994a, b). 6BH4 is an essential cofactor for the aromatic hydroxylases
and for the nitric oxide synthases (Kaufman and Fisher, 1974; Kwon
et al, 1989). The presence of a complete autocrine de novo synthesis/
recycling/regulation of 6BH4 has been identified in both epidermal
keratinocytes and melanocytes (Schallreuter et al, 1994a, b). Clearly,
the redox homeostasis of 6BH4/6-biopterin in the epidermal unit is
crucial to all the above metabolic steps, as well as to melanocyte
survival, because only the reduced cofactor is functional. One system
efficiently controlling pterin redox status in the epidermis is thio-
redoxin/thioredoxin reductase (EC 1.6.4.5) (Wood et al, 1995).
Calcium tightly controls this system via a single EF-hands binding site
on thioredoxin reductase (Schallreuter et al, 1989). Moreover, it has
been shown that melanocytes as well as keratinocytes established from
lesional epidermis express a perturbed cellular calcium homeostasis
under in vitro conditions together with impaired thioredoxin/thio-
redoxin reductase (Schallreuter et al, 1986; Schallreuter and Pittelkow,
1988; Schallreuter-Wood et al, 1996).
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Figure 6. Kinetics of melanocyte vacuolation, loss of
dendrites, and subsequent recovery after the addition of
exogenous catalase (30 mg per ml). (a) Vacuolation in the
melanocyte ( ↑ ), day 19 in culture; (b) subsequent dendrite loss
on day 25 in culture; (c) addition of bovine catalase to the
culture medium, day 27 in culture; (d) the same cell after 4 d;
(e) after 6 d; (f) after 7 d; (g) after 8 d; (h) after 9 d; (i) complete
recovery on day 13. This experiment has been reproduced in
five different cell lines.
Intracellular vacuolation in full skin biopsies and in melano-
cytes/keratinocytes established from lesional and nonlesional
epidermis of patients with vitiligo – evidence for epidermal
H2O2 stress? Varying degrees of vacuolation and degeneration in
melanocytes and keratinocytes have been reported by several investig-
ators (Moellmann et al, 1982; Bhawan and Bhutani, 1983). These
findings could implicate lipid peroxidation based on H2O2 generation.
In order to follow directly the fate of melanocytes and keratinocytes
vis-a`-vis H2O2 stress, we successfully established these cells from suction
blister tissue of lesional and nonlesional epidermis of 10 randomly
selected patients with different disease duration (1–25 y) according to
the method of Pittelkow and Shipley (1989). All patients had active
vitiligo at the time point of the study. Six patients were male and four
patients were female, with a mean age of 30.7 y (range 15–55) and
photo skin types (Fitzpatrick classification) (III, n 5 5; IV, n 5 1; V,
n 5 4). To our surprise, we were able to grow and passage melanocytes
from both lesional and nonlesional skin in all patients. These cells
developed various degrees of vacuolation after day 16 in cell culture,
whereas this phenomenon was absent in cells of healthy controls (n 5
8) cultured under the same in vitro experimental conditions. Further
to the observed vacuolation, we also noted a loss of dendrites in the
majority of melanocytes. Upon the addition of bovine catalase to the
culture medium, all cells began to re-establish dendrites and there was
no further evidence for cellular vacuolation. Figure 6 demonstrates a
time course of one representative melanocyte established from lesional
white skin showing first vacuolation, followed by a complete loss of
dendrites and subsequent sequential recovery of the cell with regrowth
of the dendrite after addition of exogenous bovine catalase to the
culture medium.
In summary, we conclude that there is in vivo evidence for epidermal
H2O2 accumulation within the entire skin of patients with vitiligo.
These results are strongly supported by the in vitro observations using
epidermal cell extracts, as well as melanocyte and keratinocyte cell
cultures established from lesional and nonlesional epidermis of patients
with this disorder. Furthermore, the in vitro results strongly support
that the entire homeostasis of the epidermis is affected in vitiligo,
despite the presence of clinically normal pigmented and white skin.
All in vivo and in vitro data implicate the involvement of the entire
epidermal compartment in this disease.
Taking all current in vivo and in vitro observations into consideration,
it appeared logical to substitute the impaired H2O2 removing systems
(i.e., catalase and glutathione peroxidase).
The development of a UVB-activated pseudocatalase complex
in association with successful repigmentation of vitiligo What
is a pseudocatalase? Pseudocatalase is not an enzyme. It is a nonpolar
bis manganese III-EDTA-(HCO–3)2 complex capable of degradation
of H2O2 to O2 and H2O after photo-activation with UVB or solar
irradiation (Pseudocatalase, Patent No. EPO58417 1A). The reduction
of the H2O2 peak can be followed in vivo over time after topical
application of this pseudocatalase preparation. Figure 7(a) demonstrates
in vitro the rapid decrease of the H2O2 signal upon the addition of
pseudocatalase (12 3 10–6 M) over 6 min. Figure 7(b) shows an
in vivo Fourier-Transform Raman spectrum in a healthy control,
where under normal circumstances no significant H2O2 was detected;
however, after exogenous exposure of the skin to 13.2 mM per mm2
H2O2 for 5 min, the peak at 875 cm
–1 was well resolved. There was
a rapid decrease of this signal with the application of pseudocatalase
after 5 min. Figure 7(c) presents the H2O2 peak of one patient’s
involved skin in vivo before and after treatment with pseudocatalase,
yielding a clearly resolved peak at 875 cm–1, which was effectively
reduced by pseudocatalase as in the control experiment. Because the
addition of exogenous calcium could correct the impaired calcium
homeostasis under in vitro conditions, the pseudocatalase complex
was incorporated into a base cream together with calcium chloride
(Schallreuter et al, 1993). Patients are required to apply this topical
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Figure 7. In vitro and in vivo H2O2 removal with pseudocatalase. (A) In vitro
Fourier-Transform Raman spectrum of H2O2 (4.4 M) at 875 cm
–1 and its
decrease over time upon the addition of pseudocatalase (the time interval
between each spectrum is 1 min). (B) In vivo Fourier-Transform Raman spectra
of (B1) normal healthy skin (- - - -) and its exposure to H2O2 (13.2 mM per
mm2) (––––) and (B2) its removal by pseudocatalase (- - - -) after 5 min.
(C) In vivo results of involved skin of a patient with vitiligo showing a native
well-defined peak at 875 cm–1 (––––) before treatment and its successful
reduction after 5 min by pseudocatalase (- - - -).
preparation twice a day on the entire integument followed by total
body low dose narrow band UVB (TL01, 310–315 nm) exposure two
to three times a week with a fixed single dose of 0.15–0.3 J per cm2
per session. It was a surprising observation that the application of broad
band UVB (280–320 nm) in association with pseudocatalase yielded
in many cases a progression of the disease. The mechanism of this
action, however, is still unclear. On the other hand, the pseudocatalase
complex can also be activated sufficiently by solar irradiation. It is
remarkable that UVB-activated pseudocatalase is 15 times more active
in the oxidation of H2O2 than natural catalase. The results of a recent
pilot study on 33 patients with vitiligo were very promising, providing
some important observations: (i) pseudocatalase treatment stopped the
progression of active vitiligo in 95% of cases; (ii) the repigmentation
process was independent of disease duration, and even patients with
long lasting disease presented an excellent recovery (Schallreuter
et al, 1995).
It is noteworthy that there must be a reservoir of a small population
of quiescent melanocytes or possible precursors even after many years
of disease, because it was possible to establish melanocyte cell cultures
from lesional and nonlesional epidermis using suction blister material
of all 10 randomly selected patients with vitiligo of different disease
duration. Here, it is interesting to note that the repigmentation
process can be followed by WOOD’s light examination due to the
disappearance of the characteristic fluorescence from the oxidized
pterins in association with a light, even repigmentation, followed by a
more pronounced and faster peri-follicular activation of melanocytes.
Histologic examination of full skin biopsies revealed a complete
recovery from epidermal vacuolation and the presence of functioning
melanocytes in all patients (n 5 18), observed by both light and
electron microscopy, as well as immunohistochemical analyses, i.e.,
staining with characteristic melanocyte markers (NK 1 beteb, HMB
45, dopa-oxidase and Fontana Masson). After complete repigmentation
the treatment was stopped and there was no new onset of vitiligo
observed. So far, these fully recovered patients have remained stable
for up to 5 y. Conversely, if the treatment was terminated before
complete repigmentation, there was a rebound phenomenon observed
in all cases. The treatment with pseudocatalase is extremely slow or
even unsuccessful in the repigmentation of fingertips, toes, and in the
medial wrist area. Currently a worldwide open trial with a stable
formulation of the pseudocatalase complex is underway. In our own
hands, the earlier observations of the pilot study have been confirmed
in 73% of the patients (n 5 146) (KUS; personal clinical observation).
In conclusion, there is increasing evidence that epidermal H2O2
accumulation fosters vitiligo. Whether H2O2 is the cause or the
consequence of the disease remains to be identified. The substitution
with a narrow band UVB-activated pseudocatalase complex in com-
bination with calcium can successfully remove epidermal H2O2 in
association with a healthy recovery of the entire epidermis and
repopulation with functioning melanocytes.
The authors are indebted to the long-lasting support and compliance by numerous patients
with vitiligo. This research has been generously supported by Stiefel International
Laboratories, the Universities of Bradford, U.K. and Greifswald, Germany. The
manuscript was typed by Helen Bartle.
REFERENCES
Armarego WLF: Chemical and biological reactions and reduced pterins. Lect Heterocycl
Chem 7:121–130, 1984
Armarego WLF, Randles D, Taguchi H: Peroxidase catalysed aerobic degradation of
5,6,7,8-tetrahydrobiopterin at physiological pH. Eur J Biochem 135:393–403, 1983
Aronoff S: Catalase: kinetics of photo-oxidation. Science 150:72–73, 1965
Beazley WD, Gaze D, Panske A, Panzig E, Schallreuter KU: Serum selenium levels and
blood glutathione peroxidase activities in vitiligo. Br J Dermatol 141:301–304, 1999
Bhawan J, Bhutani LK: Keratinocyte damage in vitiligo. J Cutaneous Path 10:207–212, 1983
Boissy R, Liu YY, Medrano EE, Nordlund JJ: Structural aberration of the rough
endoplasmic reticulum and melanosome compartmentalisation in long term cultures
of melanocytes from vitiligo patients. J Invest Dermatol 97:395–404, 1991
Bystryn JC: Serum antibodies in vitiligo patients. Clin Dermatol 2:136–145, 1989
Davis MD, Ribeiro P, Tipper J, Kaufman S: ‘‘7-Tetrahydrobiopterin’’, a naturally occurring
analogue of tetrahydrobiopterin, is a cofactor for and a potential inhibitor of the
aromatic amino acid hydrolases. Proc Natl Acad Sci USA 89:10108–10113, 1992
De Luca C, Grandinetti M, Stancato A, Passi S, Puddu P: Involvement of epidermal
oxidative stress in vitiligo and pityriasis versicolor. Pigment Cell Res 10:356, 1997
Harada T, Kagamiyama H, Hatakeyama K: Feedback regulatory mechanisms for the control
of GTP cyclohydrolase I activity. Science 260:1507–1510, 1993
Harning R, Cui J, Bystryn JC: Relation between the incidence and level of pigment cell
antibodies and disease activity in vitiligo. J Invest Dermatol 97:1078–1080, 1991
Kaufman S, Fisher DB. Pterin-requiring aromatic amino acid hydroxylases. In: Hayaishi
O (ed). Molecular Mechanisms of Oxygen Activation. New York: Academic Press, 1974,
pp. 285–369
Kwon NS, Nathan CF, Stuehr DJ: Reduced biopterin as a cofactor in the generation of
nitrogen oxides by murine macrophages. J Biol Chem 264:20496–20501, 1989
LePoole IC, Das PK, van den Wijngaard RM, Bos JD, Westerhof W: Review of
the etiopathomechanism of vitiligo: a convergence theory. Exp Dermatol 2:146–
153, 1993a
LePoole IC, van den Wijngaard RM, Westerhof W, Dutrieux RP, Das PK: Presence or
absence of melanocytes in vitiligo lesions: an immunohistochemical investigation.
J Invest Dermatol 100:816–822, 1993b
LePoole IC, van den Wijngaard RM, Smit NP, Oesting J, Westerhof W, Pavel S: Catechol-
O-methyltransferase in vitiligo. Arch Dermatol Res 286:81–86, 1994
Maresca V, Roccella M, Roccella F, et al: Increased sensitivity to peroxidative agents as a
possible pathogenic factor of melanocyte damage in vitiligo. J Invest Dermatol
109:310–313, 1997
Marks DB, Marks AD, Smith CM. Oxygen metabolism and oxygen toxicity. In: Basic
Medical Biochemistry: A clinical approach. Williams and Wilkins. Baltimore, 1996, pp.
327–340
Medrano EE, Nordlund JJ: Successful culture of adult human melanocytes obtained from
normal and vitiligo donors. J Invest Dermatol 95:441–445, 1990
Milstien S, Jaffe H, Kowlessur D, Bonner TI: Purification and cloning of the GTP
cyclohydrolase I feedback regulatory protein, GFRP. J Biol Chem 271:19743–
19751, 1996
Moellmann G, Klein-Angerer S, Scollay DA, Nordlund JJ, Lerner A: Extracellular granular
material and degeneration of keratinocytes in normally pigmented epidermis of
patients with vitiligo. J Invest Dermatol 79:321–330, 1982
Morrone A, De Picardo M, Luca C, Terminali O, Passi S, Ippolito F: Catecholamines
and vitiligo. Pigment Cell Res 5:58–62, 1992
Nordlund JJ, Ortonne JP: Vitiligo and depigmentation. Current Prob Dermatol 4:3–30, 1992
Norris DA, Kissinger GM, Naughton GM, Bystryn JC: Evidence for immunologic
mechanisms in human vitiligo: Patients’ sera induce damage to human melanocytes
in vitro by complement-mediated damage and antibody-dependent cellular
cytotoxicity. J Invest Dermatol 90:783–789, 1988a
Norris DA, Capin L, Muglia JJ, Osborn RL, Zerbe GO, Bystryn JC, Tonnesen MG:
Enhanced susceptibility of melanocytes to different immunologic effector mechanisms
in vitro. Pigment Cell Res 1 (Suppl.):113–123, 1988b
Ortonne JP, Bose SK: Vitiligo: Where do we stand? Pigment Cell Res 8:61–72, 1993
Pittelkow MR, Shipley GD: Serum free culture of normal human melanocytes: growth
kinetics and growth factor requirements. J Cell Physiol 140:565–576, 1989
Schallreuter KU, Pittelkow MR: Defective calcium uptake in keratinocyte cell cultures
from vitiliginous skin. Arch Dermatol Res 280:137–139, 1988
Schallreuter KU, Pittelkow MR, Wood JM: Free radical reduction by thioredoxin reductase
at the surface of normal and vitiliginous human keratinocytes. J Invest Dermatol
87:728–732, 1986
96 SCHALLREUTER ET AL JID SYMPOSIUM PROCEEDINGS
Schallreuter KU, Pittelkow MR, Wood JM: EF-hands calcium binding regulates the
thioredoxin reductase/thioredoxin electron transfer in human keratinocytes. Biochem
Biophys Res Commun 162:1311–1316, 1989
Schallreuter KU, Wood JM, Berger J: Low catalase levels in the epidermis of patients with
vitiligo. J Invest Dermatol 97:1081–1085, 1991
Schallreuter KU, Wood JM, Pittelkow MR, Swanson NN, Steinkraus V: Increased in vitro
expression of beta-2-adrenoceptors in differentiating lesional keratinocytes of vitiligo
patients. Arch Dermatol Res 285:216–220, 1993
Schallreuter KU, Wood JM, Pittelkow MR, Gu¨tlich M, Lemke KR, Ro¨dl W, Swanson
NN, Hitzemann K, Ziegler I: Regulation of melanin biosynthesis in the human
epidermis by tetrahydrobiopterin. Science 263:1444–1446, 1994a
Schallreuter KU, Wood JM, Lemke KR, Pittelkow MR, Lindsey NJ, Gu¨tlich M, Ziegler I:
Defective tetrahydrobiopterin and catecholamine biosynthesis in the depigmentation
disorder vitiligo. Biochim Biophys Acta 1226:181–192, 1994b
Schallreuter KU, Bu¨ttner G, Pittelkow MR, Wood JM, Swanson NN, Ko¨rner C: The
cytotoxicity of 6-biopterin to human melanocytes. Biochem Biophys Res Commun
204:43–48, 1994c
Schallreuter KU, Wood JM, Lemke KR, Levenig C: Treatment of vitiligo with a topical
application of pseudocatalase and calcium in combination with short term UVB
exposure: a case study on 33 patients. Dermatol 190:223–229, 1995
Schallreuter KU, Wood JM, Pittelkow MR, Bu¨ttner G, Swanson NN, Ko¨rner C, Ehrke
C: Increased monoamine oxidase A activity in the epidermis of patients with vitiligo.
Arch Dermatol Res 288:14–18, 1996
Schallreuter KU, Zschiesche M, Moore J, Panske A, Hibberts NA, Herrmann FH,
Metelmann HR, Sawatzki J: In vivo evidence for compromised phenylalanine
metabolism in vitiligo. Biochem Biophys Res Commun 243:395–399, 1998a
Schallreuter KU, Wood JM, Ko¨rner C, Harle KM, Schulz-Douglas V, Werner ER: 6-
tetrahydrobiopterin functions as a UVB-light switch for de novo melanogenesis.
Biochim Biophys Acta 1382: 339–344, 1998b
Schallreuter-Wood KU, Pittelkow MR, Swanson NN: Defective calcium transport in
vitiliginous melanocytes. Arch Dermatol Res 288:11–13, 1996
Stryer L: Biochemistry. Freeman & Co., New York, 1988, pp. 592–593
Wood JM, Schallreuter-Wood KU, Lindsey NJ, Callaghan S, Gardner MLG: A specific
tetrahydrobiopterin binding domain on tyrosinase controls melanogenesis. Biochem
Biophys Res Commun 206:480–485, 1995
Yohn JJ, Norris DA, Yrastorza DG, Buno IJ, Leff JA, Hake SS, Repine JE: Disparate
antioxidant enzyme activities in cultured human cutaneous fibroblasts, keratinocytes
and melanocytes. J Invest Dermatol 97:405–409, 1991
